Site içinde arama yapın

bir ses eklendi Health

2026-06-08 06:36:36 -

Psychedelic Medicine Market: How Are Australia and Europe Shaping Global Psychedelic Access Models?

International psychedelic medicine regulation — Australia's 2023 rescheduling of psilocybin and MDMA as controlled medicines for therapeutic use, Switzerland's 723 patient authorizations in 2024, and Germany's 2025 compassionate-use program — creates the most commercially dynamic market segment, with the Psychedelic Medicine Market reflecting international regulatory innovation as...

0 Yorumlar 0 hisse senetleri 319 Views 0 önizleme